Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.

A diminutive protein prompts a closer look at DNA dark matter.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.